EmTech Asia 2020 to be held in Singapore from 4 – 5 August 2020 reveals several key speakers on the impact of research on the future of health care.
The conference on emerging technologies is co-organized by MIT Technology Review and Koelnmesse. Looking to discuss the future of health care, the speakers will cover three main topics concerning technology and health care.
First would be the use of wearable technology to address the incidence of cancer. In 2018, there were 18 million cases of cancer and a predicted 30 million cases in 2040. As the second leading cause of death globally, cancer is a global public health concern and economic burden.
Steven Tucker, co-founder of wearable technology company Re:Mission Health, will be describing the relationship between cancer and obesity which he believes will affect younger adults disproportionately. He will also be discussing how wearable technology can reduce the risk of relapse in cancer survivors.
Living in our gastrointestinal system is a complex ecosystem made up of bacteria, fungi, and viruses, collectively termed microbiome. Besides gastrointestinal conditions such as Crohn’s disease, the gut microflora has shown to have implications to other disease such as autism, Parkinson’s disease and obesity.
Taking advantage of modern genetic sequencing and computing tools, Dr. Jeremy Lim and his team at the Asian Microbiome Library (AMiLi) seek to appreciate the role of human microbiome in disease and health. Dr. Lim will also share how the microbiome will help save lives and highlight the importance of dedicated research and development in Asia.
Growth in ageing populations in Asia has put a strain on health care spending, by 2030 it is estimated that Asia will be home to 500 million people over 65 years, making up more than 60 percent of the global population in that age group.
At EmTech Asia 2020, Graham Ruby, principal investigator at Google-backed company Calico, will discuss as statistical framework connecting mortality statistics with the biology of ageing which was proposed by Benjamin Gompertz in 1825 and still valid today. The framework draws an unusual model species to guide future research on the biology of healthy ageing: the naked mole rat. [APBN]